Fredrik Jäderling

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Article: EUROPEAN UROLOGY ONCOLOGY. 2024;:S2588-9311(24)00244-X
Repeat Prostate Cancer Screening using Blood-based Risk Prediction or Prostate-specific Antigen in the Era of Magnetic Resonance Imaging-guided Biopsies : A Secondary Analysis of the STHLM3-MRI Randomized Clinical Trial.
Discacciati A; Abbadi A; Clements MS; Annerstedt M; Carlsson S; Grönberg H; Jäderling F; Eklund M; Nordström T
Journal article: BJU INTERNATIONAL. 2024
A novel approach to integrated prostate cancer diagnostics: insights from MRI, prostate biopsy, and pathology reports in a pilot study
Thimansson E; Axen E; Jaderling F; Styrke J; Nyberg M; Hageman N; Ivarsson J; Malmberg G; Gaspar V; Tornblom M
Journal article: ACTA ONCOLOGICA. 2024;63:816-821
A pilot study of AI-assisted reading of prostate MRI in Organized Prostate Cancer Testing
Thimansson E; Zackrisson S; Jaderling F; Alterbeck M; Jiborn T; Bjartell A; Wallstrom J
Article: EUROPEAN UROLOGY ONCOLOGY. 2024;:S2588-9311(24)00229-3
Diagnostic Effects of Omitting Systematic Biopsies in Prostate Cancer Screening.
Chandra Engel J; Eklund M; Jäderling F; Palsdottir T; Falagario U; Discacciati A; Nordström T
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2024;67:s14
PE012 Can we rely solely on MRI/targeted biopsies and excluding systematic biopsies preoperatively in radical prostatectomy?
Hagman A; Pellegrino F; Egevad L; Jäderling FJ; Falagario U; Proietti F; Brasetti A; Lantz A; Wiklund P
Article: BMC UROLOGY. 2024;24(1):168
Tailoring biopsy strategy in the MRI-fusion prostate biopsy era: systematic, targeted or neither?
Jaderling F; Bergman M; Engel JC; Mortezavi A; Picker W; Haug ES; Eklund M; Nordstrom T
Article: JOURNAL OF MAGNETIC RESONANCE IMAGING. 2024;60(2):458-468
Prostate Age Gap: An MRI Surrogate Marker of Aging for Prostate Cancer Detection
Fernandez-Quilez A; Nordstrom T; Jaederling F; Kjosavik SR; Eklund M
Article: EUROPEAN RADIOLOGY. 2024;34(7):4801-4809
Manual prostate MRI segmentation by readers with different experience: a study of the learning progress
Langkilde F; Masaba P; Edenbrandt L; Gren M; Halil A; Hellstrom M; Larsson M; Naeem AA; Wallstrom J; Maier SE; Jaderling F
Article: THE LANCET ONCOLOGY. 2024;25(7):879-887
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study.
Saha A; Bosma JS; Twilt JJ; van Ginneken B; Bjartell A; Padhani AR; Bonekamp D; Villeirs G; Salomon G; Giannarini G; Kalpathy-Cramer J; Barentsz J; Maier-Hein KH; Rusu M; Rouvière O; van den Bergh R; Panebianco V; Kasivisvanathan V; Obuchowski NA; Yakar D; Elschot M; Veltman J; Fütterer JJ; de Rooij M; Huisman H; PI-CAI consortium
Journal article: INVESTIGATIVE UROLOGY. 2024;211(5S):e969
PD45-06 ACCURACY OF THE MRI 5-POINT LIKERT SCORE TO PREDICT EXTRA-PROSTATIC EXTENSION AND SEMINAL VESICLE INVASION IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER AND DEVELOPMENT OF a NEW MRI-BASED NOMOGRAM
Pellegrino F; Falagario UG; Proietti F; Brasetti A; Hagman A; Briganti A; Montorsi F; Carrieri G; Lantz A; Akre O; Aly M; Egevad L; Jaderling F; Wiklund P
Article: JAMA NETWORK OPEN. 2024;7(4):e247131
Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening: The STHLM3-MRI Randomized Clinical Trial
Bjornebo L; Discacciati A; Falagario U; Vigneswaran HT; Jaderling F; Gronberg H; Eklund M; Nordstrom T; Lantz A
Journal article: EUROPEAN UROLOGY. 2024;85:s1611
Multiplex blood-test and Magnetic Resonance Imaging (MRI) for prostate cancer screening: Results from the 2nd screening round in the STHLM3-MRI trial
Discacciati A; Abbadi A; Chandra J; Annerstedt M; Glaessgen A; Carlsson S; Jaderling F; Gronberg H; Eklund M; Nordstrom T
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2024;61:29-36
The Capio Prostate Cancer Center Model for Prostate Cancer Diagnostics-Real-world Evidence from 2018 to 2022
Palsdottir T; Soderback H; Jaderling F; Bergman M; Vigneswaran H; Gronberg H
Journal article: EUROPEAN UROLOGY. 2024;85:s459-s460
Accuracy of the MRI 5-point Likert score to predict extra-prostatic extension and seminal vesicle invasion in patients undergoing radical prostatectomy for prostate cancer and development of a new MRI-based nomogram.
Pellegrino F; Falagario UG; Proietti F; Brasetti A; Hagman A; Briganti A; Montorsi F; Carrieri G; Lantz A; Akre O; Aly M; Egevad L; Jaderling F; Wiklund P
Article: JAMA NETWORK OPEN. 2024;7(2):e2354577
Repeated Prostate Cancer Screening Using Prostate-Specific Antigen Testing and Magnetic Resonance Imaging A Secondary Analysis of the STHLM3-MRI Randomized Clinical Trial
Nordstrom T; Annerstedt M; Glaessgen A; Carlsson S; Clements M; Abbadi A; Groenberg H; Jaderling F; Eklund M; Discacciati A
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(4_SUPPL):295
The Capio Prostate Cancer Center model for prostate cancer diagnostics using Stockholm3, MRI, and targeted biopsies: Real-world evidence from 2018 to 2022
Palsdottir T; Soderback H; Jaderling F; Bergman M; Gronberg H
Journal article: ANNALS OF ONCOLOGY. 2023;34:s1577
The Capio Prostate Cancer Center model for prostate cancer diagnostics using Stockholm3, MRI and targeted biopsies: Real-world evidence from 2018 to 2022
Vigneswaran H; Soderback H; Jaderling F; Bergman M; Gronberg H; Palsdottir T
Article: LAKARTIDNINGEN. 2023;120:23077
[Improved prostate cancer diagnostics with a structured pathway including »Stockholm 3« test, MRI and targeted perineal biopsies].
Söderbäck H; Jäderling F; Wimmerkranz F; Andersson J; Bergman M; Nordström T; Grönberg H
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2023;51:89-94
Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer
Lantz A; Nordlund P; Falagario U; Joderling F; Ozbek O; Clements M; Discacciati A; Gronberg H; Eklund M; Stricker P; Emberton M; Aly M; Nordstrom T
Journal article: EUROPEAN UROLOGY. 2023;83:s1268
Repeat prostate cancer screening using prostate-specific antigen, a multiplex bloodtest and magnetic resonance imaging: 2nd screening round outcomes of STHLM3-MRI
Nordstrom T; Discacciati A; Annerstedt M; Mannsikka K; Glaessgen A; Carlsson S; Jaderling F; Gronberg H; Eklund M
Article: BMJ HEALTH & CARE INFORMATICS. 2022;29(1):e100588
Effect of digital-enabled multidisciplinary therapy conferences on efficiency and quality of the decision making in prostate cancer care
Ronmark E; Hoffmann R; Skokic V; de Klerk-Starmans M; Jaderling F; Vos P; Gayet MCW; Hofstraat H; Janssen M; Akre O; Vincent PH
Article: EUROPEAN UROLOGY. 2022;82(1):12-19
Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study
Hao S; Heintz E; Ostensson E; Discacciati A; Jaderling F; Gronberg H; Eklund M; Nordstrom T; Clements MS
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;41:63-73
Characteristics of Patients in SPCG-15-A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer
Gongora M; Stranne J; Johansson E; Bottai M; Karlsson CT; Brasso K; Hansen S; Jakobsen H; Jaderling F; Lindberg H; Lilleby W; Petersen PM; Mirtti T; Olsson M; Rannikko A; Roder MA; Vincent PH; Akre O
Article: ULTRASOUND IN OBSTETRICS AND GYNECOLOGY. 2021;58(5):773-779
Interobserver agreement of transvaginal ultrasound and magnetic resonance imaging in local staging of cervical cancer
Palsdottir K; Fridsten S; Blomqvist L; Alagic Z; Fischerova D; Gaurilcikas A; Hasselrot K; Jaderling F; Testa AC; Sundin A; Epstein E
Article: MAGNETIC RESONANCE IN MEDICINE. 2021;86(4):2025-2033
Mapping prostatic microscopic anisotropy using linear and spherical b-tensor encoding: A preliminary study
Nilsson M; Eklund G; Szczepankiewicz F; Skorpil M; Bryskhe K; Westin C-F; Lindh C; Blomqvist L; Jaderling F
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2021;385(10):908-920
MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Groenberg H; Nordstroem T
Article: THE LANCET ONCOLOGY. 2021;22(9):1240-1249
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial
Nordstrom T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jaderling F; Eklund M; Gronberg H
Article: WORLD JOURNAL OF UROLOGY. 2021;39(6):1797-1804
Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancer
Bjornebo L; Olsson H; Nordstrom T; Jaderling F; Gronberg H; Eklund M; Lantz A
Journal article: EUROPEAN UROLOGY. 2021;79:s1429
P1014 Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, magnetic resonance imaging and targeted prostate biopsies: The STHLM3MRI trial
Nordström T; Discacciati A; Bergman M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H
Journal article: EUROPEAN UROLOGY. 2021;79:s1430
P1015 MRI-targeted or systematic biopsies in prostate cancer screening: The STHLM3MRI trial
Eklund M; Jäderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Grönberg H; Nordström T
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2021;113(5):632-640
Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS)
Olsson H; Nordstrom T; Jaderling F; Egevad L; Vigneswaran HT; Annerstedt M; Gronberg H; Eklund M; Lantz A
Article: WORLD JOURNAL OF UROLOGY. 2021;39(4):1153-1159
Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies
Lantz A; Haug ES; Picker W; Crippa A; Jaderling F; Mortezavi A; Nordstrom T
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2020;54(4):318-322
The value of a first MRI and targeted biopsies after several years of active surveillance for low-risk prostate cancer - results from the SAMS trial
Carlsson S; Bratt O; Kristiansson D; Jaderling F
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2020;19:e182
58 Adding random systematic biopsies to MRI-fusion targeted prostate biopsy procedures: Always, in selected cases, or never?
Bergman MCA; Mortezawi A; Picker W; Aly M; Jäderling F; Haug E; Eklund M; Nordström T
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6_suppl):tps379
Incorporating mpMRI and biomarkers in active surveillance protocols: The prospective Stockholm3 Active Surveillance trial (STHLM3AS).
Lantz A; Olsson H; Nordström T; Jäderling F; Egevad L; Annerstedt M; Gronberg H; Eklund M
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6_suppl):tps378
MRI-targeted biopsies in prostate cancer screening and the value of its combination with blood-based risk-prediction: The randomized, diagnostic study STHLM3MRI.
Nordström T; Discacciati A; Jäderling F; Karlsson SG; Aly M; Gronberg H; Eklund M
Article: EUROPEAN UROLOGY ONCOLOGY. 2019;2(5):490-496
A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance Imaging
Palsdottir T; Nordstrom T; Aly M; Jaderling F; Clements M; Gronberg H; Eklund M
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2019;22(3):391-398
Preoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery
Jaderling F; Akre O; Aly M; Bjorklund J; Olsson M; Adding C; Oberg M; Blomqvist L; Nyberg T; Wiklund P; Carlsson S
Article: BMJ OPEN. 2019;9(8):e027860
PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design
Ahlberg MS; Adami H-O; Beckmann K; Bertilsson H; Bratt O; Cahill D; Egevad L; Garmo H; Holmberg L; Johansson E; Rannikko A; Van Hemelrijck M; Jaderling F; Wassberg C; Aberg UWN; Bill-Axelson A
Article: BMJ OPEN. 2019;9(6):e027816
Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
Nordstrom T; Jaderling F; Carlsson S; Aly M; Gronberg H; Eklund M
Article: ONCOLOGIST. 2019;24(6):745-e213
Safety and Activity of Sorafenib in Addition to Vinflunine in Post-Platinum Metastatic Urothelial Carcinoma (Vinsor): Phase I Trial
Shah C-H; Pappot H; Agerbaek M; Holmsten K; Jaderling F; Yachnin J; Gryback P; von der Maase H; Ullen A
Article: EUROPEAN UROLOGY. 2018;74(6):722-728
Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging
Gronberg H; Eklund M; Picker W; Aly M; Jaderling F; Adolfsson J; Landquist M; Haug ES; Strom P; Carlsson S; Nordstrom T
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2018;52(5-6):313-320
SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer
Stranne J; Brasso K; Brennhovd B; Johansson E; Jaderling F; Kouri M; Lilleby W; Petersen PM; Mirtti T; Pettersson A; Rannikko A; Thellenberg C; Akre O
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2018;17(14):e3001
P162 Safety and activity of sorafenib in addition to vinflunine in post-platinum metastatic urothelial carcinoma (Vinsor): Phase I trial
Shah C-H; Pappot H; Agerbæk M; Holmsten K; Jäderling F; Yachnin J; Grybäck P; Von Der Maase H; Ullén A
Article: LAKARTIDNINGEN. 2018;115:FCDT
[Improved prostate cancer diagnostics with a struc-tured pathway including the Stockholm3 test and MRI--targeted biopsies - experiences from Capio S:t Göran Prostate Cancer Center].
Bergman M; Hjälm Ericsson M; Jäderling F; Meurling E; Thorstensson A; Nordström T; Henrik G
Article: ACTA RADIOLOGICA OPEN. 2018;7(2):2058460118754607
Accuracy in local staging of prostate cancer by adding a three-dimensional T2-weighted sequence with radial reconstructions in magnetic resonance imaging
Jaderling F; Nyberg T; Oberg M; Carlsson S; Skorpil M; Blomqvist L
Article: PLOS ONE. 2018;13(6):e0199477
Comparison of 3D printed prostate models with standard radiological information to aid understanding of the precise location of prostate cancer: A construct validation study
Ebbing J; Jaderling F; Collins JW; Akre O; Carlsson S; Hoijer J; Olsson MJ; Wiklund PN
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2017;16(10):e2628-e2629
O2 A multistep approach for detection of prostate cancer using prostate-specific antigen, the Stockholm 3 Test, and MRI-targeted Biopsies: Initial data from the STHLM3 MRI Project
Nordström; Picker W; Aly M; Jäderling F; Adolfsson J; Ström P; Haug ES; Eklund M; Carlsson S; Grönberg H
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2017;16(6):e2279-e2280
PE24 Comparison of 3D printed prostate models with standard radiological information to aid understanding of the precise location of prostate cancer: A construct validation study
Ebbing J; Jäderling F; Collins JW; Akre O; Carlsson S; Höijer J; Olsson MJ; Wiklund PN
Article: BJU INTERNATIONAL. 2017;119(2):289-297
Diagnostic accuracy of computed tomography urography and visual assessment during ureterorenoscopy in upper tract urothelial carcinoma
Grahn A; Melle-Hannah M; Malm C; Jaderling F; Radecka E; Beckman M; Brehmer M
Article: ONCOLOGY LETTERS. 2016;12(2):1293-1300
Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis
Holmsten K; Dohn LH; Jensen NV; Shah C-H; Jaderling F; Pappot H; Ullen A
Article: BJU INTERNATIONAL. 2016;118(2):205-212
Oncological and functional outcomes 1 year after radical prostatectomy for very-low-risk prostate cancer: results from the prospective LAPPRO trial
Carlsson S; Jaderling F; Wallerstedt A; Nyberg T; Stranne J; Thorsteinsdottir T; Carlsson SV; Bjartell A; Hugosson J; Haglind E; Steineck G
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2016;50(4):260-266
Accurate prediction tools in prostate cancer require consistent assessment of included variables
Jaderling F; Nyberg T; Blomqvist L; Bjartell A; Steineck G; Carlsson S
Article: LAKARTIDNINGEN. 2015;112:DFZ3
[Go for MRI in the diagnosis of prostate cancer].
Bratt O; Ahlgren G; Andrén O; Blomqvist L; Carlsson S; Damber JE; Hugosson J; Jäderling F; Karlsson CT; Robinson D
Article: EUROPEAN RADIOLOGY. 2010;20(3):630-639
Evaluation of image quality and lesion perception by human readers on 3D CT colonography: comparison of standard and low radiation dose
Fisichella VA; Bath M; Johnsson AA; Jaderling F; Bergsten T; Persson U; Mellingen K; Hellstrom M
Article: CLINICAL RADIOLOGY. 2009;64(10):972-982
Computer-aided detection (CAD) as a second reader using perspective filet view at CT colonography: effect on performance of inexperienced readers
Fisichella VA; Jaderling F; Horvath S; Stotzer P-O; Kilander A; Bath M; Hellstrom M
Article: ACTA RADIOLOGICA. 2009;50(3):244-255
Primary Three-Dimensional Analysis with Perspective-Filet View Versus Primary Two-Dimensional Analysis: Evaluation of Lesion Detection by Inexperienced Readers at Computed Tomographic Colonography in Symptomatic Patients
Fisichella VA; Jaderling F; Horvath S; Stotzer P-O; Kilander A; Hellstrom M
Journal article: OPPORTUNISTIC PATHOGENS. 1993;5(4):209-216
Fine specificity and neutralizing activity of human serum antibodies directed to the major antigenic region on gp 116 of human cytomegalovirus
Silvestri M; Jäderling F; Rudén U; Ohlin M; Sundqvist V-A
Visa fler

Alla övriga publikationer

Corrigendum: EUROPEAN UROLOGY. 2022;82(1):e21
Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study (vol 82, pg 12, 2022)
Hao S; Heintz E; Ostensson E; Discacciati A; Jaderling F; Gronberg H; Eklund M; Nordstrom T; Clements MS
Editorial comment: JOURNAL OF UROLOGY. 2022;207(1):231
Re: MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Gronberg H; Nordstrom T
Preprint: MEDRXIV. 2021
Cost-effectiveness of Stockholm3 test and magnetic resonance imaging in prostate cancer screening: a microsimulation study
Hao S; Heintz E; Östensson E; Discacciati A; Jäderling F; Grönberg H; Eklund M; Nordström T; Clements M
Preprint: SSRN ELECTRONIC JOURNAL. 2021
Prostate Cancer Screening Using a Combination of Risk-Prediction, Magnetic Resonance Imaging and Targeted Prostate Biopsies: A Randomised Trial
Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H
Conference publication: EUROPEAN UROLOGY. 2021;79:S1429
Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, magnetic resonance imaging and targeted prostate biopsies: The STHLM3MRI trial
Nordstrom T; Discacciati A; Bergman M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jaderling F; Eklund M; Gronberg H
Conference publication: EUROPEAN UROLOGY. 2021;79:S1430
MRI-targeted or systematic biopsies in prostate cancer screening: The STHLM3MRI trial
Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Gronberg H; Nordstrom T
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6)
Incorporating mpMRI and biomarkers in active surveillance protocols: The prospective Stockholm3 Active Surveillance trial (STHLM3AS)
Lantz A; Olsson H; Nordstrom T; Jaderling F; Egevad L; Annerstedt M; Gronberg H; Eklund M
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6)
MRI-targeted biopsies in prostate cancer screening and the value of its combination with blood-based risk-prediction: The randomized, diagnostic study STHLM3MRI
Nordstrom T; Discacciati A; Jaderling F; Karlsson SG; Aly M; Gronberg H; Eklund M
Conference publication: SCANDINAVIAN JOURNAL OF UROLOGY. 2019;53:40
Improved prostate cancer diagnostics with a structured pathway including the Stockholm3 test and MRI-targeted biopsies led by nurses
Thorstenson A; Melander-Bergstrom C; Cavalli-Bjorkman C; Bergman M; Hjelm-Eriksson M; Jaderling F; Meurling E; Nordstrom T; Gronberg H
Editorial comment: EUROPEAN UROLOGY FOCUS. 2017;3(6):526-528
Detection of Prostate Cancer Using a Multistep Approach with Prostate-specific Antigen, the Stockholm 3 Test, and Targeted Biopsies: The STHLM3 MRI Project
Nordstrom T; Picker W; Aly M; Jaderling F; Adolfsson J; Strom P; Haug ES; Eklund M; Carlsson S; Gronberg H
Corrigendum: ONCOLOGY LETTERS. 2017;13(6):5035
Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis (vol 12, pg 1293, 2016)
Holmsten K; Dohn L; Jensen NV; Shah C-H; Jaderling F; Pappot H; Ullen A
Thesis / dissertation: 2016
Preoperative local staging of prostate cancer : aspects on predictive models, magnetic resonance imaging and interdisciplinary teamwork
Jäderling, Fredrik
Conference publication: SCANDINAVIAN JOURNAL OF UROLOGY. 2013;47:30-31
Diagnostic accuracy of ct and ureteroscopy in urothelial carcinoma of the upper urinary tract
Grahn A; Melle-Hannah M; Malm C; Jaderling F; Radecka EE; Beckman M; Brehmer M

Forskningsbidrag

Artificial intelligence for reproducible MRI diagnosis of prostate cancer
Swedish Research Council
1 January 2021 - 31 December 2023
SPCG-15: SURGERY VERSUS RADIOTHERAPY FOR LOCALLY ADVANCED PROSTATE CANCER: A RANDOMIZED CLINICAL TRIAL.
Swedish Research Council
1 December 2017 - 31 December 2018

Anställningar

Anknuten till Forskning, Molekylär medicin och kirurgi, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för molekylär medicin och kirurgi, Karolinska Institutet, 2017
Läkarexamen, Karolinska Institutet, 1997

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI